DUBLIN–(BUSINESS WIRE)–The “Balloon Catheters- Market Overview, Competitive Landscape and Market Forecast-2026” Report has been added to from ResearchAndMarkets.com offer.
Global Balloon Catheters Market was valued at USD 4.23 Billion in 2020 growing at a CAGR of 8.78% during the forecast period 2021 to 2026 to reach USD 7.00 Billion by 2026.
Factors such as the increasing prevalence of lifestyle disorders such as hypertension and obesity which stand as major risk factors for the development of cardiovascular disease as well as brain aneurysms, the increase in incidence of cancers of the pelvic region affecting the urinary system to varying degrees, the growing geriatric population base where age itself plays a major role in disease etiology, and technical innovation in the development of products, such as the manufacture of drug-coated balloon catheters for delivery of drugs to the site of action, among other factors, are expected to drive the balloon catheter market.
Balloon Catheter Market Dynamics:
One of the key aspects of the balloon catheter market is the growing prevalence of cancers, especially of the lower pelvis, such as prostate, colon, rectum, bladder, among others. According to data provided by the International Agency for Research on Cancer, in 2020, 431,288 new cases of kidney cancer were reported worldwide.
The same source also presented the data for bladder cancer for which 573,278 new cases were reported worldwide. Cancers originating in the lower pelvis region often impact the ureters, and the cancerous growth can block the ureter and affect the flow of urine from the kidney to the bladder. This leads to accumulation of urine in the kidneys and eventually affects kidney function.
Therefore, in such cases, a nephrostomy is performed where in the nephrostomy balloon catheters are deployed to create a passage for urine. Hence, the demand for nephrostomy balloon catheters would witness an increase owing to the increasing prevalence of cancers, especially in the pelvic region, thereby driving the growth of the global balloon catheters market over the forecast period (2021 -2026).
Another key factor driving the demand for balloon catheters is the growing prevalence of cardiovascular diseases. According to the World Health Organization (WHO) (2021), cardiovascular disease (CVD) is the leading cause of death worldwide, with an estimated 17.9 million deaths per year worldwide.
Cardiovascular diseases include myocardial infarction, congestive heart failure, acute coronary syndrome and other disorders. Atherosclerosis and coronary heart disease further progress to give rise to serious cardiovascular forms such as myocardial infarction, stroke, peripheral arterial disease and heart attack. The majority of cardiovascular diseases are treated by procedures such as percutaneous transuminal coronary angioplasty (PTCA) in which balloon catheters are widely used.
Thus, the growing prevalence of cardiovascular diseases is expected to drive the conductance of higher number of PCI procedures, which in turn would drive the demand for PTCA balloon catheters, eventually driving the growth of the balloon catheter market in the years to come. to come.
However, the specific limitations associated with each type of balloon catheter, probable procedural risks, and product recalls can be some challenging aspects for the growth of the balloon catheter market.
The balloon catheter market has witnessed a decline in sales due to the implementation of measures to curb the global spread of COVID19 infection. One of the key milestones in the COVID outbreak has been extensive selective treatment and the suspension of outpatient consultations. This has reduced the demand for such catheters in the market as healthcare system guidelines around the world have changed to temporarily focus on the management of patients exposed to COVID-19 infection.
A decline in product demand has been observed in the balloon catheter market as supply chains and product manufacturing activities have been affected across the globe during the lockdown phase in 2020. However, the market seems to be recovering, with the recovery of the global supply chain and resumption of installation activity, providing a positive outlook for the balloon catheter market during the forecast period.
Main topics covered:
1. Introduction to Balloon Catheters Market Report
2. Executive Summary of Balloon Catheters Market
2.1. Scope of the study
2.2. Market in brief
2.3. Competitive evaluation
2.4. Financial benchmarking
3. Regulatory analysis
3.1. United States
4. Key Factor Analysis of Balloon Catheters Market
4.1. Balloon Catheter Market Drivers
4.1.1. Increasing prevalence of cardiovascular disease
4.1.2. Growing prevalence of brain aneurysms
4.1.3. Increased prevalence of cancers in the pelvic region
4.1.4. Technical innovation in product development
4.2. Constraints and Challenges of the Balloon Catheters Market
4.2.1. Limitations associated with different types of catheters
4.2.2. Product recalls
4.3. Balloon Catheter Market Opportunities
4.3.1. Improving the Safety Prospects of Balloon Catheters
4.3.2. Improving Design Shortcomings of Balloon Catheters
5. Porter’s Five Forces Analysis of Balloon Catheters Market
5.1. Bargaining power of suppliers
5.2. Bargaining power of consumers
5.3. The threat of new entrants
5.4. The threat of substitutes
5.5. Competitive Rivalry
6. Impact Analysis of COVID-19 on Balloon Catheters Market
7. Balloon Catheter Market Layout
7.1. By product type
7.1.1. PTA balloon catheters
7.1.2. PTCA Balloon Catheters
7.1.3. Occlusion balloon catheters
7.1.4. Foley catheters
7.1.5. Nephrostomy Balloon Catheters
7.1.6. Drug-eluting catheters
7.2. By type of catheter
7.2.1. fixed wire
7.2.2. On the wire
7.2.3. Quick exchange
7.3. By balloon type
7.4. Per end user
7.4.2. Specialized clinics
7.5. By geography
8. Global Balloon Catheter Market Share Analysis – 3 to 5 Key Companies
9. Balloon Catheters Market Company and Product Profiles
Boston Scientific Society
B. Braun Melsungen AG
Microport Scientific Corporation
Nipro Medical Society
Summit Medical (Innovia Medical) Well Lead Medical Co., Ltd
Lepu Medical Technology (Beijing) Co., Ltd
Cardiovascular Systems Inc.
For more information on this report, visit https://www.researchandmarkets.com/r/bmo2lu